No products in the cart.
Return To ShopNo products in the cart.
Return To ShopCellCept 500 Roche, the brand name for mycophenolate mofetil, is an immunosuppressant medication primarily prescribed for organ transplant patients to prevent rejection. While its use in clinical settings is well-documented, athletes have increasingly turned to CellCept for its potential benefits. The medication works by inhibiting the proliferation of lymphocytes, which can support recovery and reduce inflammation during training and competition. Understanding the implications of its use in sports contexts is crucial for athletes seeking a competitive edge while remaining within ethical boundaries.
The primary mechanism of action for CellCept involves the inhibition of the enzyme inosine monophosphate dehydrogenase (IMPDH). This inhibition affects lymphocyte activation and proliferation, thereby modulating the immune response. For athletes, this can translate into enhancements in performance through reduced inflammation and enhanced recovery times after intense workouts. By lowering inflammation, athletes may experience quicker healing of muscle tears, strains, or injuries commonly sustained during rigorous training regimes. However, the impact of such enhancements is nuanced. CellCept does not directly increase muscle mass or strength, but it may allow athletes to train harder and recover faster, potentially leading to improved performance over time.
Acquiring CellCept 500 Roche can be straightforward, but athletes must prioritize safety and legality when considering its use. It is crucial to obtain CellCept from licensed pharmacies and reputable suppliers to ensure the product’s authenticity. Some online pharmacies may offer CellCept without a prescription; however, this poses significant risks including receiving counterfeit medications. Legitimate pharmacies often have systems in place to verify prescriptions, ensuring a higher standard of quality and safety. Considerations for storage include keeping the medication in a cool, dry place and out of reach of children, which will help maintain its efficacy. Consulting a healthcare professional before use is essential to understand how it fits into personal health and performance strategies.
While CellCept can offer potential benefits for athletes, it is not without its risks. Common side effects include gastrointestinal issues such as nausea and diarrhea, as well as increased susceptibility to infections due to its immunosuppressive properties. More severe reactions, although rare, can include liver or kidney issues, and there may be a risk of certain types of cancer over long-term use. Therefore, athletes must carefully weigh the benefits against these potential side effects and work closely with healthcare providers to monitor their health. Understanding the safety limits and recommendations for dosage is critical in minimizing adverse outcomes while trying to leverage its performance-enhancing capabilities.
CellCept 500 Roche may offer several benefits for athletes, provided it is used judiciously and under professional supervision. Here’s a summary of potential benefits:
In conclusion, while CellCept 500 Roche can be a tool for enhancing athletic performance through improved recovery, its use must be approached with caution and awareness of the associated risks. Engaging with healthcare professionals for proper guidance can help athletes make informed decisions that prioritize both performance and health.
| Active substance | Mycophenolate Mofetil |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Blood levels of mycophenolic acid may be monitored to adjust dose |
| Also known as | MMF |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Typically has no direct effect on blood pressure |
| Trade name | CellCept |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 2-Morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate |
| Formula | C23H31NO7 |
| Substance class | Immunosuppressant, specifically a prodrug of mycophenolic acid |
| Main action | Inhibits inosine monophosphate dehydrogenase, leading to suppression of lymphocyte proliferation |
| Half-life | Approximately 17.9 hours (for the active metabolite mycophenolic acid) |
| Dosage (medical) | Typically 1g orally twice a day |
| Dosage (sports) | Not applicable as it does not enhance athletic performance |
| Effects | Prevents organ rejection in transplant patients |
| Side effects | Gastrointestinal disturbances, increased risk of infections, leukopenia, anemia |
| Use in sports | Not typically used in sports due to its immunosuppressive effects |
| Manufacturer | Roche |
€90.00
Reviews
There are no reviews yet.